|
⚲
|
| Keyboard |
| Sanofi
✚
|
|
|---|---|
| CIK # | 0001121404 |
| Sector | Form 13F Holdings | Value ($M) | |
|---|---|---|---|
| MeiraGTx Holdings PLC | 105.6 | ||
| Inhibrx Biosciences Inc | 77.8 | ||
| Novavax Inc | 56.0 | ||
| Anaptysbio Inc | 30.4 | ||
| Maplight Therapeutics Inc | 18.5 | ||
| Immuneering Corp | 14.3 | ||
| Tokai Pharmaceuticals Inc | 2.5 | ||
| Homology Medicines Inc | 1.6 | ||
| Holdings by Sector ($M) |
|---|
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-HR | [0001121404] | |
| 3 | [0001121404] | |
| 4 | [0001121404] | |
| 6-K | [0001121404] | |
| SC 13D | [0001121404] | |
| SC 13G | [0001121404] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Translate Bio Inc TBIO
Common Stock, par value $0.001 per share
|
2021-09-14 | Buy | 20,515,985 | $38.00 | 779,607,430 |
|
Translate Bio Inc TBIO
Common Stock, par value $0.001 per share
|
2021-09-14 | Buy | 51,467,612 | $38.00 | 1,955,769,256 |
|
Icosavax Inc ICVX
Series A-1 Preferred Stock (par value, $0.0001) · derivative
|
2021-08-02 | Conversion | 12,480,498 | ||
|
Icosavax Inc ICVX
Series B-1 Preferred Stock (par value, $0.0001) · derivative
|
2021-08-02 | Conversion | 354,393 | ||
|
Icosavax Inc ICVX
Common Stock (par value, $0.0001)
|
2021-08-02 | Buy | 66,667 | $15.00 | 1,000,005 |
|
Icosavax Inc ICVX
Common Stock (par value, $0.0001)
|
2021-08-02 | Conversion | 3,088,502 | $0.00 | |
|
Inozyme Pharma Inc INZY
Common Stock (par value $0.0001)
|
2020-07-28 | Buy | 81,250 | $16.00 | 1,300,000 |
|
Inozyme Pharma Inc INZY
Common Stock (par value $0.0001)
|
2020-07-28 | Conversion | 438,875 | $0.00 | |
|
Inozyme Pharma Inc INZY
Series A Convertible Preferred Stock (par value, $0.0001) · derivative
|
2020-07-28 | Conversion | 3,279,720 | $0.00 | |
|
Regeneron Pharmaceuticals Inc REGN
Common Stock
|
2020-06-09 | Sell | 120,234 | $597.48 | 71,837,410 |
|
Regeneron Pharmaceuticals Inc REGN
Common Stock
|
2020-05-29 | Sell | 20,421,899 | $509.85 | 10,412,105,205 |
|
Regeneron Pharmaceuticals Inc REGN
Common Stock
|
2020-05-29 | Sell | 2,399,552 | $509.85 | 1,223,411,587 |
|
Regeneron Pharmaceuticals Inc REGN
Common Stock
|
2020-03-09 | Sell | 128,914 | $489.65 | 63,122,740 |
|
Regeneron Pharmaceuticals Inc REGN
Common Stock
|
2019-09-10 | Sell | 172,904 | $281.15 | 48,611,960 |
|
Fulcrum Therapeutics Inc FULC
Common Stock (par value $0.001)
|
2019-07-22 | Conversion | 464,285 | $0.00 | |
|
Fulcrum Therapeutics Inc FULC
Common Stock (par value $0.001)
|
2019-07-22 | Buy | 93,750 | $16.00 | 1,500,000 |
|
Fulcrum Therapeutics Inc FULC
Series B Preferred Stock (par value $0.001) · derivative
|
2019-07-22 | Conversion | 3,250,000 | $0.00 | |
|
Regeneron Pharmaceuticals Inc REGN
Common Stock
|
2019-03-08 | Sell | 131,115 | $412.17 | 54,041,670 |
|
MyoKardia Inc MYOK
Common Stock (par value $0.0001)
|
2019-02-13 | Sell | 4,168,899 | $37.66 | 157,000,736 |
|
Regeneron Pharmaceuticals Inc REGN
Common Stock
|
2018-09-06 | Sell | 104,552 | $406.68 | 42,519,207 |
| showing 20 of 200 most recent transactions | |||||